Bone Marrow Transplantation

TABLE 1

FROM:

Allogeneic bone marrow transplantation for juvenile myelomonocytic leukemia: a single center experience of 23 patients

E T Korthof, P P Snijder, A A de Graaff, A C Lankester, R G M Bredius, L M Ball, J L W T Lie, J M Vossen and R M Egeler

BACK TO ARTICLE

Table 1. Patient data at diagnosis, pretransplant treatment and interval to BMT

UPN Age Leukocytes (109/l) Monocytes (109/l) Platelets (109/l) HbF (%) Cytogenetics Pretransplant treatment Interval to BMT (months)
031a 4.918516.72415nb BU, Leukeran, Vincristin8.48
036a 0.48.31.316NTc nAra-C, Vincristin, Etoposide5.82
1071.5404.04514.4nIFN, CY4.41
140.1d 5.312.23.41742.9-7Inductione ANLL4.14
1775.93.11.123NT-7Induction+consolidatione ANLL6.58
194d 0.379.932.02611.7n6TG, Ara-C, induction ANLL2.24
196d 1.0414.14215nInduction ANLL2.30
210.1d 1.869.89.12624-6,-8,+mar2Induction, consolidation, intensificatione ANLL9.21
2261.130.75.811NT-7Splenectomy, induction ANLL11.31
24010.51628.14420.9nInduction ANLL2.27
27210.832.57.8153NT-7Induction ANLL10.98
27311.94.11.48NT-7, +21None8.78
2986.932.82.68733.3nIsotretinoide, splenectomy, Vincristin10.55
3291.340.68.121840n6MP, Vincristin, Ara-C, Etoposide5.98
3397.63.81.4563.5-7None5.79
355d 0.874.616.41815.9n6MP, Ara-C47.90
3693.774.813.529NTdup (3)(q21q29)IFN8.28
3723.789.714.4Not known13.0nSplenectomy, IFN, Ara-C9.21
4121.079.39.5224.3n6MP, Ara-C5.92
4190.36212.423NTn6MP9.86
4302.636.45.52941.2n6MP, Ara-C, induction ANLL14.17
4451.6251.3346NTnNone8.88
450.10.9338.66NT-7, +216MP4.93

a Described in Van't Veer-Korthof.16

b n, normal.

c NT, not tested.

d Described in Niemeyer et al.8

e Induction, consolidation and intensification ANLL as described in the text.

BACK TO ARTICLE